Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1998 | 06-1998 | 03-1998 | 12-1997 | 09-1997 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,080 | -1,680 | -3,820 | -11,578 | -12,106 |
| Depreciation Amortization | 2,330 | 1,640 | 860 | 4,389 | 3,336 |
| Other Working Capital | -5,560 | -9,710 | -2,020 | -2,651 | -3,559 |
| Other Operating Activity | 1,810 | 1,060 | 780 | 3,762 | 3,104 |
| Operating Cash Flow | $-4,500 | $-8,690 | $-4,200 | $-6,078 | $-9,225 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,380 | -1,090 | -870 | -2,145 | -1,480 |
| Other Investing Activity | 1,670 | 4,210 | -4,130 | -36,754 | -24,000 |
| Investing Cash Flow | $-710 | $3,120 | $-5,000 | $-38,899 | $-25,480 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -1,110 | -800 | -450 | 39,424 | 40,518 |
| Financing Cash Flow | $-1,110 | $-800 | $-450 | $39,424 | $40,518 |
| Beginning Cash Position | 28,920 | 28,920 | 28,920 | 34,475 | 34,475 |
| End Cash Position | 22,590 | 22,530 | 19,250 | 28,921 | 40,288 |
| Net Cash Flow | $-6,320 | $-6,380 | $-9,660 | $-5,554 | $5,813 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,500 | -8,690 | -4,200 | -6,078 | -9,225 |
| Free Cash Flow | -4,500 | -8,690 | -4,200 | -6,078 | -9,225 |